At the rate we are going, our products are going to be very in demand for a long time yet and this whole pandemic is definitely going to assist with penetration. If they can penetrate the US market with some tailwinds, we could see a huge increase in revenue as the US market only makes up for a very small proportion of our revenue at the moment.
$520k CF positive with another month to go, we are well ahead of forecasts and could definitely get to $1m cash inflow noting that we probably haven’t received cash for a lot of the sales this quarter.
I definitely think $300m cap is a valuation which would reflect the IP that we hold (not accounting for sales growth which would add to this).
PR holds a lot of this company and would love to see this to a $ billion company. who wouldn’t when his stake will be worth $200m.
With no CR needed anymore, the fundies will have to pay up imo.
Let’s see how this pans out.
- Forums
- ASX - By Stock
- UCM in the AFR
UCM
uscom limited
Add to My Watchlist
0.00%
!
1.9¢

At the rate we are going, our products are going to be very in...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.759M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500000 | 1.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 46000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500000 | 0.014 |
1 | 132270 | 0.012 |
1 | 100000 | 0.010 |
1 | 150000 | 0.008 |
2 | 2000000 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 46000 | 1 |
0.020 | 63256 | 1 |
0.021 | 24866 | 1 |
0.022 | 6549 | 1 |
0.055 | 95083 | 2 |
Last trade - 16.21pm 27/06/2025 (20 minute delay) ? |
Featured News
UCM (ASX) Chart |
Day chart unavailable
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online